Kevin N. Heller
Keine laufenden Positionen mehr
Profil
Kevin N.
Heller worked as a Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He then worked as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
From 2018 to 2020, he served as Chief Medical Officer at NextCure, Inc. In 2021, he worked as Executive Vice President-Research & Development at Jasper Therapeutics, Inc. Dr. Heller holds a doctorate degree from George Washington University and an undergraduate degree from Yale University.
Ehemalige bekannte Positionen von Kevin N. Heller
| Unternehmen | Position | Ende |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17.03.2022 |
| NEXTCURE, INC. | Chief Tech/Sci/R&D Officer | 04.08.2020 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01.04.2018 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01.05.2015 |
Ausbildung von Kevin N. Heller
| George Washington University | Doctorate Degree |
| Yale University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| NEXTCURE, INC. | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
